Clinical Trial Update: Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated inhaled doxorubicin in patients with primary lung cancer or lung metastases; the study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lung Cancer

Drugs mentioned

• Doxorubicin (Adriamycin) (doxorubicin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED